AETERNA ZENTARIS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.65 CAD | -0.38% |
|
-0.75% | +3.11% |
Chart calendar Aeterna Zentaris Inc.
34d2140498fd47dbb03f79a92be.eiMX8mnIGJ46RozmIeJLlH0qWr5y3VWopHa7SBJ-5g8.AxJawBCENdYPE9OBGNUj5CdQDOYW8BT5wUT4El4a1Tsxbi-5MPh31Fsy3Q~ed07db1fb44ce7b3eba37f9180a82099
Upcoming events on Aeterna Zentaris Inc.
Past events on Aeterna Zentaris Inc.
| 27/03/2024 05:35 pm | Q4 2023 Earnings Release |
| 12/03/2024 08:30 pm | Extraordinary Shareholders Meeting |
| 12/03/2024 | Extraordinary Shareholders Meeting |
| 09/11/2023 06:30 pm | Q3 2023 Earnings Release |
| 25/10/2023 07:30 pm | Virtual Investor Ask the CEO Conference |
| 11/09/2023 04:30 pm | H.C. Wainwright Global Investment Conference |
| 09/08/2023 05:35 pm | Q2 2023 Earnings Release |
| 13/07/2023 07:30 pm | Virtual Investor Summer Spotlight Series |
| 14/06/2023 07:30 pm | Annual General Meeting |
| 10/05/2023 02:30 am | Q1 2023 Earnings Release |
| 23/03/2023 05:35 pm | Q4 2022 Earnings Release |
| 20/01/2023 01:30 am | Virtual Investor: Companies to Watch Conference |
| 03/11/2022 05:36 pm | Q3 2022 Earnings Release |
| 04/08/2022 03:15 am | Interim 2022 Earnings Release |
| 21/07/2022 | Reverse Split: 1 of 25 |
| 15/07/2022 07:30 pm | Annual General Meeting - Adjourned |
| 06/07/2022 07:30 pm | Annual General Meeting |
| 15/06/2022 10:00 pm | JMP Securities Life Sciences Conference |
| 12/06/2022 02:40 pm | Autoimmunity International Congress - Parallel Session 12 - CNS - Central Nervous System |
| 10/06/2022 | Autoimmunity International Congress - Antigen presentation on MHC |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,65 | 5,26 2,41 117.9% | 5,64 4,22 33.81% | 4,50 4,38 2.67% |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -8,67 -7,42 -16.81% | -23,6 -15,8 -49.62% | -18,0 -16,4 -10.02% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -8,48 -7,49 -13.24% | -22,7 -14,9 -52.47% | -16,6 -15,7 -5.6% |
|
Net income Million USD | Released Forecast Spread | -5,12 | -8,37 -7,36 -13.74% | -22,7 -14,9 -52.47% | -16,6 -15,7 -5.6% |
|
EPS USD | Released Forecast Spread | -3,00 | -1,75 -1,50 -16.67% | -4,68 -3,04 -53.95% | -3,41 -3,22 -5.9% |
| Announcement Date | 24/03/21 | 28/03/22 | 23/03/23 | 27/03/24 |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,47 0,63 453.91% | 1,52 0,74 105% | -0,22 1,31 -116.95% | 1,86 1,34 39.33% | 2,49 1,06 134.43% | 2,13 0,90 136.44% | 2,25 1,14 97.02% | 0,00 2,28 -99.87% | 0,12 0,00 2925% |
|
EBIT Million USD | Released Forecast Spread | -3,42 -2,18 -57.38% | -2,81 -2,70 -4.38% | -4,72 -3,38 -39.73% | -3,72 -3,43 -8.48% | -12,4 -4,53 -172.99% | -4,21 -5,20 19.1% | -2,86 -4,26 32.98% | -4,55 -2,97 -53.35% | -6,40 -4,76 -34.48% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,17 -2,18 -45.56% | -2,64 -2,70 2.04% | -4,22 -3,38 -24.92% | -3,42 -3,43 0.29% | -12,5 -4,53 -175.16% | -4,26 -5,20 18.17% | -2,52 -4,26 40.89% | -4,15 -2,97 -39.7% | -5,64 -4,76 -18.48% |
|
Net income Million USD | Released Forecast Spread | -3,19 -2,18 -46.48% | -2,64 -2,70 2.04% | -4,20 -3,38 -24.44% | -3,42 -3,43 0.29% | -12,5 -4,53 -175.16% | -4,26 -5,20 18.17% | -2,52 -4,26 40.89% | -4,15 -2,97 -39.7% | -5,64 -4,76 -18.48% |
|
EPS USD | Released Forecast Spread | -0,50 -0,50 0% | -0,50 -0,50 0% | -0,87 -0,68 -27.94% | -0,70 -0,68 -2.94% | -2,56 -0,93 -175.27% | -0,88 -1,07 17.76% | -0,52 -0,87 40.23% | -0,85 -0,61 -39.34% | -1,16 -0,97 -19.59% |
| Announcement Date | 28/03/22 | 10/05/22 | 03/08/22 | 03/11/22 | 23/03/23 | 09/05/23 | 09/08/23 | 09/11/23 | 27/03/24 |
| Today 01:35 am | QIAGEN N.V.: Q1 2024 Earnings Release |
| 30/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 04:00 pm | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 04:00 pm | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 04:30 pm | ALKERMES PLC: Q1 2024 Earnings Release |
| 02/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Aeterna Zentaris Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AEZS Stock
- Calendar Aeterna Zentaris Inc.
